Hitting 5,000 steps per day could slow down the progression of Alzheimer's disease by years, promising research has suggested. US scientists, who tracked almost 300 adults, found those who met the ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in closely watched trials, drugmaker Novo Nordisk ...

Novo Nordisk announced Monday that in two closely watched studies, an oral version of semaglutide — the active ingredient in weight loss drugs — failed to help slow the progression of Alzheimer’s. The ...